| Group of urticaria |
Subtypes |
Treatment |
| Spontaneous urticaria |
Acute urticaria |
➣ Non-sedating H1-antihistamines
➣ Severe cases: urticaria associated with angioedema – Glucocorticosteroids
(0.5-1 mg/Kg/day);
anaphylactic shock – Epinephrine (0.01 mg/Kg/dose)
|
| |
Chronic urticaria |
➣ Non-sedating H1-antihistamines
(up to 4 doses daily)
➣ Non-sedating H1-antihistamines may be associated with:
• Montelukast
• H2-antihistamines
• Hydroxychloroquine
• Dapsone
• Oral glucocorticosteroids
• Cyclosporine A
➣ Other options:
• Plasmapherezis
• Intravenous immunoglobulins
• Omalizumab |
| Physical urticaria |
Dermographism |
➣ Non-sedating H1-antihistamines
➣ alternative therapeutic: options for treatment of chronic urticaria
|
| |
Delayed pressure urticaria |
➣ Non-sedating H1-antihistamines –high dose
➣ Other treatment options:
• Non sedating H1-antihistamines + Montelukast
• Non sedating H1-antihistamines + glucocorticosteroids |
| |
Cold urticaria |
➣ Non-sedating H1-antihistamines
➣ Penicillin i.m./p.o.
Docycyline p.o.
➣ Omalizumab |
| |
Solar urticaria |
➣ Non-sedating H1-antihistamines
➣ Other treatment options:
Plasmapheresis+PUVA
Intravenous immunoglobulins
Omalizumab
Cyclosporine A, Hydroxychloroquine |
| |
Aquagenic urticaria |
➣ Non-sedating H1- antihistamines in increased dose (regularly or as needed) |
| |
Vibratory urticaria |
Avoidance |
| Other types of urticaria |
Cholinergic urticaria |
➣ Non-sedating H1- antihistamines in increased dose (regularly or as needed)
➣ Omalizumab
➣ Danazol |
| |
Contact urticaria |
➣ Non-sedating H1- antihistamines in increased dose (regularly or as needed) |
| |
Exercise induced urticaria |
➣ Non-sedating H1- antihistamines in increased dose (regularly or as needed) |
